Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes

      A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.

      Keywords

      To read this article in full you will need to make a payment
      ISN Member Login
      ISN Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Couser W.G.
        • Remuzzi G.
        • Mendis S.
        • et al.
        The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.
        Kidney Int. 2011; 80: 1258-1270
        • Neuen B.L.
        • Chadban S.
        • Demaio A.R.
        • et al.
        Chronic kidney disease and the global NCDs agenda.
        BMJ Global Health. 2017; 2e000380
        • Jager K.J.
        • Fraser S.D.S.
        The ascending rank of chronic kidney disease in the global burden of disease study.
        Nephrol Dial Transplant. 2017; 32: ii121-ii128
        • BD 2015 Mortality and Causes of Death Collaborators
        Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
        Lancet. 2016; 388: 1459-1544
        • Luyckx V.A.
        • Miljeteig I.
        • Ejigu A.M.
        • et al.
        Ethical challenges in the provision of dialysis in resource-constrained environments.
        Semin Nephrol. 2017; 37: 273-286
        • Foreman K.J.
        • Marquez N.
        • Dolgert A.
        • et al.
        Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.
        Lancet. 2018; 392: 2052-2090
        • Liyanage T.
        • Ninomiya T.
        • Jha V.
        • et al.
        Worldwide access to treatment for end-stage kidney disease: a systematic review.
        Lancet. 2015; 385: 1975-1982
        • Anand S.
        • Bitton A.
        • Gaziano T.
        The gap between estimated incidence of end-stage renal disease and use of therapy.
        PLoS One. 2013; 8e72860
        • USRDS
        USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States.
        USRDS, Bethesda, MD2017
        • Bello A.K.
        • Levin A.
        • Tonelli M.
        • et al.
        Assessment of global kidney health care status.
        JAMA. 2017; 317: 1864-1881
        • Bello A.K.
        • Levin A.
        • Tonelli M.
        • et al.
        Global Kidney Health Atlas: A Report by the International Society of Nephrology on the Current State of Organization and Structures for Kidney Care Across the Globe.
        International Society of Nephrology, Brussels, Belgium2017
        • Harris D.C.H.
        • Davies S.J.
        • Finkelstein F.O.
        • et al.
        Increasing access to integrated ESKD care as part of universal health coverage.
        Kidney Int. 2019; 95: S1-S33
        • White S.L.
        • Chadban S.J.
        • Jan S.
        • et al.
        How can we achieve global equity in provision of renal replacement therapy?.
        Bull World Health Organ. 2008; 86: 229-237
        • Schieppati A.
        • Remuzzi G.
        Chronic renal diseases as a public health problem: epidemiology, social, and economic implications.
        Kidney Int Suppl. 2005; : S7-S10
        • Caskey F.J.
        • Kramer A.
        • Elliott R.F.
        • et al.
        Global variation in renal replacement therapy for end-stage renal disease.
        Nephrol Dial Transplant. 2011; 26: 2604-2610
        • Wetmore J.B.
        • Collins A.L.
        Global challenges imposed by the growth of end-stage renal disease.
        Renal Repl Ther. 2016; 2: 15
        • Coresh J.
        • Jafar T.H.
        Disparities in worldwide treatment of kidney failure.
        Lancet. 2015; 385: 1926-1928
        • Hecking M.
        • Bieber B.A.
        • Ethier J.
        • et al.
        Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
        PLoS Med. 2014; 11e1001750
        • Bamgboye E.L.
        The challenges of ESRD care in developing economies: sub-Saharan African opportunities for significant improvement.
        Clin Nephrol. 2016; 86: 18-22
        • Li P.K.
        • Chow K.M.
        • Van de Luijtgaarden M.W.
        • et al.
        Changes in the worldwide epidemiology of peritoneal dialysis.
        Nat Rev Nephrol. 2017; 13: 90-103
        • Mehrotra R.
        • Devuyst O.
        • Davies S.J.
        • et al.
        The current state of peritoneal dialysis.
        J Am Soc Nephrol. 2016; 27: 3238-3252
        • Karopadi A.N.
        • Mason G.
        • Rettore E.
        • et al.
        The role of economies of scale in the cost of dialysis across the world: a macroeconomic perspective.
        Nephrol Dial Transplant. 2014; 29: 885-892
        • Wang V.
        • Maciejewski M.L.
        • Coffman C.J.
        • et al.
        Impacts of geographic distance on peritoneal dialysis utilization: refining models of treatment selection.
        Health Serv Res. 2017; 52: 35-55
        • Li P.K.
        • Chow K.M.
        Peritoneal dialysis-first policy made successful: perspectives and actions.
        Am J Kidney Dis. 2013; 62: 993-1005
        • Sedor J.R.
        • Watnick S.
        • Patel U.D.
        • et al.
        ASN End-Stage Renal Disease Task Force: perspective on prospective payments for renal dialysis facilities.
        J Am Soc Nephrol. 2010; 21: 1235-1237
        • Liu F.X.
        • Gao X.
        • Inglese G.
        • et al.
        A global overview of the impact of peritoneal dialysis first or favored policies: an opinion.
        Perit Dial Int. 2015; 35: 406-420
        • Tantivess S.
        • Werayingyong P.
        • Chuengsaman P.
        • et al.
        Universal coverage of renal dialysis in Thailand: promise, progress, and prospects.
        BMJ. 2013; 346: f462
        • Schaefer F.
        • Borzych-Duzalka D.
        • Azocar M.
        • et al.
        Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network Registry.
        Perit Dial Int. 2012; 32: 399-409
        • Luyckx V.A.
        • Smyth B.
        • Harris D.C.H.
        • Pecoits-Filho R.
        Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey.
        Kidney Int Suppl. 2020; 10: e10-e18
        • Teerawattananon Y.
        • Luz A.
        • Pilasant S.
        • et al.
        How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?.
        Health Res Policy Syst. 2016; 14: 21
        • Wolfe R.A.
        • Ashby V.B.
        • Milford E.L.
        • et al.
        Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
        N Engl J Med. 1999; 341: 1725-1730
        • Pruthi R.
        • Curnow E.
        • Roderick P.
        • et al.
        UK Renal Registry 17th Annual Report: chapter 11: Centre variation in access to renal transplantation in the UK (2008–2010).
        Nephron. 2015; 129: 247-256
        • Ghods A.J.
        • Nasrollahzadeh D.
        Gender disparity in a live donor renal transplantation program: assessing from cultural perspectives.
        Transplant Proc. 2003; 35: 2559-2560
        • Lawton P.D.
        • McDonald S.P.
        • Snelling P.L.
        • et al.
        Organ transplantation in Australia: inequities in access and outcome for indigenous Australians.
        Transplantation. 2017; 101: e345-e346
        • Hod T.
        • Goldfarb-Rumyantzev A.S.
        The role of disparities and socioeconomic factors in access to kidney transplantation and its outcome.
        Ren Fail. 2014; 36: 1193-1199
        • Irving M.J.
        • Tong A.
        • Jan S.
        • et al.
        Factors that influence the decision to be an organ donor: a systematic review of the qualitative literature.
        Nephrol Dial Transplant. 2012; 27: 2526-2533
        • Morton R.L.
        • Turner R.M.
        • Howard K.
        • et al.
        Patients who plan for conservative care rather than dialysis: a national observational study in Australia.
        Am J Kidney Dis. 2012; 59: 419-427
        • Da Silva-Gane M.
        • Wellsted D.
        • Greenshields H.
        • et al.
        Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis.
        Clin J Am Soc Nephrol. 2012; 7: 2002-2009
        • van de Luijtgaarden M.W.
        • Noordzij M.
        • van Biesen W.
        • et al.
        Conservative care in Europe—nephrologists' experience with the decision not to start renal replacement therapy.
        Nephrol Dial Transplant. 2013; 28: 2604-2612
        • Seah A.S.
        • Tan F.
        • Srinivas S.
        • et al.
        Opting out of dialysis—exploring patients' decisions to forego dialysis in favour of conservative non-dialytic management for end-stage renal disease.
        Health Expect. 2015; 18: 1018-1029
        • Murtagh F.E.
        • Burns A.
        • Moranne O.
        • et al.
        Supportive care: comprehensive conservative care in end-stage kidney disease.
        Clin J Am Soc Nephrol. 2016; 11: 1909-1914
        • Okamoto I.
        • Tonkin-Crine S.
        • Rayner H.
        • et al.
        Conservative care for ESRD in the United Kingdom: a national survey.
        Clin J Am Soc Nephrol. 2015; 10: 120-126
        • Hemmelgarn B.R.
        • James M.T.
        • Manns B.J.
        • et al.
        Rates of treated and untreated kidney failure in older vs younger adults.
        JAMA. 2012; 307: 2507-2715
        • The Australian Institute of Health and Welfare
        Incidence of end-stage kidney disease in Australia 1997–2013. Contract No.: Catalogue number PHE211.
        Australian Institute of Health and Welfare, Canberra, Australia2016
        • Rosa-Diez G.
        • Gonzalez-Bedat M.
        • Ferreiro A.
        • et al.
        Burden of end-stage renal disease (ESRD) in Latin America.
        Clin Nephrol. 2016; 86: 29-33
        • See E.J.
        • Alrukhaimi M.
        • Ashuntantang G.E.
        • et al.
        Global coverage of health information systems for kidney disease: availability, challenges, and opportunities for development.
        Kidney Int Suppl. 2018; 8: 74-81
        • Counil E.
        • Cherni N.
        • Kharrat M.
        • et al.
        Trends of incident dialysis patients in Tunisia between 1992 and 2001.
        Am J Kidney Dis. 2008; 51: 463-470
        • Davids M.R.
        • Caskey F.J.
        • Young T.
        • et al.
        Strengthening renal registries and ESRD research in Africa.
        Semin Nephrol. 2017; 37: 211-223
        • Noppakun K.
        • Ingsathit A.
        • Pongskul C.
        • et al.
        A 25-year experience of kidney transplantation in Thailand: report from the Thai Transplant Registry.
        Nephrology (Carlton). 2015; 20: 177-183
        • Lim T.O.
        • Goh A.
        • Lim Y.N.
        • et al.
        Review article: use of renal registry data for research, health-care planning and quality improvement: what can we learn from registry data in the Asia-Pacific region?.
        Nephrology (Carlton). 2008; 13: 745-752
        • Gonzalez-Bedat M.
        • Rosa-Diez G.
        • Pecoits-Filho R.
        • et al.
        Burden of disease: prevalence and incidence of ESRD in Latin America.
        Clin Nephrol. 2015; 83: 3-6
      1. Registro LatinoAmericano de Dialysis y Translante Renal. INFORME 2015–2016. Available at: https://slanh.net/wp-content/uploads/2018/10/INFORME-2015-2016.pdf. Accessed January 20, 2020.

        • Davids M.R.
        • Eastwood J.B.
        • Selwood N.H.
        • et al.
        A renal registry for Africa: first steps.
        Clin Kidney J. 2016; 9: 162-167
        • Rodriguez R.A.
        • Hotchkiss J.R.
        • O'Hare A.M.
        Geographic information systems and chronic kidney disease: racial disparities, rural residence and forecasting.
        J Nephrol. 2013; 26: 3-15
        • Liu F.X.
        • Rutherford P.
        • Smoyer-Tomic K.
        • et al.
        A global overview of renal registries: a systematic review.
        BMC Nephrol. 2015; 16: 31
        • de Moraes T.P.
        • Figueiredo A.E.
        • de Campos L.G.
        • et al.
        Characterization of the BRAZPD II cohort and description of trends in peritoneal dialysis outcome across time periods.
        Perit Dial Int. 2014; 34: 714-723

      Linked Article

      • Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Dialysis provisions and end-stage kidney disease (ESKD) care represents an important challenge, particularly in low-resource settings. The purpose of this project was to survey nephrologists from low- and lower middle-income countries about their experiences in the following domains: (i) Dialysis funding and eligibility; (ii) dialysis-procurement mechanisms; (iii) clinical protocols for dialysis; (iv) monitoring of dialysis outcomes; and (v) barriers to care for ESKD. One hundred and twenty responses from 31 low- and middle-income countries, from 8 ISN regions, were included in the analysis.
        • Full-Text
        • PDF
      • The role of kidney transplantation as a component of integrated care for chronic kidney disease
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Kidney transplant provides superior outcomes to dialysis as a treatment for end-stage kidney disease. Therefore, it is essential that kidney transplantation be part of an integrated treatment and management plan for chronic kidney disease (CKD). Developing an effective national program of transplantation is challenging because of the requirement for kidney donors and the need for a multidisciplinary team to provide expert care for both donors and recipients. This article outlines the steps necessary to establish a national kidney transplant program, starting with the requirement for effective legislation that provides the legal framework for transplantation whilst protecting organ donors, their families, recipients, and staff and is an essential requirement to combat organ trafficking.
        • Full-Text
        • PDF
      • Considerations on equity in management of end-stage kidney disease in low- and middle-income countries
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care).
        • Full-Text
        • PDF
      • Global case studies for chronic kidney disease/end-stage kidney disease care
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          The prevalence of chronic kidney disease and its risk factors is increasing worldwide, and the rapid rise in global need for end-stage kidney disease care is a major challenge for health systems, particularly in low- and middle-income countries. Countries are responding to the challenge of end-stage kidney disease in different ways, with variable provision of the components of a kidney care strategy, including effective prevention, detection, conservative care, kidney transplantation, and an appropriate mix of dialysis modalities.
        • Full-Text
        • PDF
      • Framework for establishing integrated kidney care programs in low- and middle-income countries
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Secular increases in the burden of kidney failure is a major challenge for health systems worldwide, especially in low- and middle-income countries (LMICs) due to growing demand for expensive kidney replacement therapies. In LMICs with limited resources, the priority of providing kidney replacement therapies must be weighed against the prevention and treatment of chronic kidney disease, other kidney disorders such as acute kidney injury, and other noncommunicable diseases, as well as other urgent public health needs.
        • Full-Text
        • PDF
      • Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          A key component of treatment for all people with advanced kidney disease is supportive care, which aims to improve quality of life and can be provided alongside therapies intended to prolong life, such as dialysis. This article addresses the key considerations of supportive care as part of integrated end-stage kidney disease care, with particular attention paid to programs in low- and middle-income countries. Supportive care should be an integrated component of care for patients with advanced chronic kidney disease, patients receiving kidney replacement therapy (KRT), and patients receiving non-KRT conservative care.
        • Full-Text
        • PDF
      • Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Substantial heterogeneity in practice patterns around the world has resulted in wide variations in the quality and type of dialysis care delivered. This is particularly so in countries without universal standards of care and governmental (or other organizational) oversight. Most high-income countries have developed such oversight based on documentation of adherence to standardized, evidence-based guidelines. Many low- and lower-middle-income countries have no or only limited organized oversight systems to ensure that care is safe and effective.
        • Full-Text
        • PDF
      • Developing the ethical framework of end-stage kidney disease care: from practice to policy
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Ethical issues relating to end-stage kidney disease (ESKD) care are increasingly being discussed by clinicians and ethicists but are still infrequently considered at a policy level or in the education and training of health care professionals. In most lower-income countries, access to kidney replacement therapies such as dialysis is not universal, leading to overt or implicit rationing of resources and potential exclusion from care of those who are unable to sustain out-of-pocket payments. These circumstances create significant inequities in access to ESKD care within and between countries and impose emotional and moral burdens on patients, families, and health care workers involved in decision-making and provision of care.
        • Full-Text
        • PDF
      • Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Prevention and early detection of kidney diseases in adults and children should be a priority for any government health department. This is particularly pertinent in the low-middle-income countries, mostly in Asia, Africa, Latin America, and the Caribbean, where up to 7 million people die because of lack of end-stage kidney disease treatment. The nephrology workforce (nurses, technicians, and doctors) is limited in these countries and expanding the size and expertise of the workforce is essential to permit expansion of treatment for both chronic kidney disease and end-stage kidney disease.
        • Full-Text
        • PDF
      • The second Global Kidney Health Summit outputs: developing a strategic plan to increase access to integrated end-stage kidney disease care worldwide
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          The articles in this edition of Kidney International Supplements describe the background, rationale, and action plans for developing a strategic approach to increase access to integrated end-stage kidney disease (ESKD) care worldwide over the next decade. It is estimated that the number of people dying globally with ESKD for want of kidney replacement therapy is up to 3 times the number who receive it.1 Kidney transplantation meets only a small fraction of this therapeutic need. Many patients with advanced kidney disease, whether receiving kidney replacement therapy or not, suffer considerably because they have no access to supportive care.
        • Full-Text
        • PDF